" /> Ifetroban - CISMeF





Preferred Label : Ifetroban;

NCIt definition : An orally bioavailable thromboxane (TxA2) and prostaglandin H2 (PGH2) (TP) receptor antagonist, with anti-thrombotic, anti-hypertensive, anti-asthmatic and potential anti-metastatic activities. Upon administration, ifetroban targets and binds to TxA2 and PGH2 receptors, thereby preventing the activity of both TxA2 and PGH2 and disrupting their downstream signaling pathways. This prevents platelet activation, aggregation and thrombosis. It also prevents vascular constriction and causes vasodilation. In addition, as cancer cells use platelets to metastasize to different parts of the body, ifetroban can reduce the stickiness of the platelets and prevent metastasis. TxA2 causes vascular contraction and platelet activation.;

UNII : E833KT807K;

InChIKey : BBPRUNPUJIUXSE-DXKRWKNPSA-N;

CAS number : 143443-90-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 143443-90-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Chemical formula : C25H32N2O5;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
25/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.